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kstaines@rvc.ac.ukAbstractAberrant redeployment of the ‘transient’ events responsible for bone development and
postnatal longitudinal growth has been reported in some diseases in what is otherwise
inherently ‘stable’ cartilage. Lessons may be learnt from the molecular mechanisms
underpinning transient chondrocyte differentiation and function, and their application may
better identify disease aetiology. Here, we review the current evidence supporting this
possibility. We firstly outline endochondral ossification and the cellular and physiological
mechanisms by which it is controlled in the postnatal growth plate. We then compare the
biology of these transient cartilaginous structures to the inherently stable articular cartilage.
Finally, we highlight specific scenarios in which the redeployment of these embryonic
processes may contribute to disease development, with the foresight that deciphering those
mechanisms regulating pathological changes and loss of cartilage stability will aid future
research into effective disease-modifying therapies.Key Words
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dedJournal of Endocrinology
(2013) 219, R1–R12IntroductionThe transition of cartilage to bone is the basis by which all
long bones form. This transition is tightly regulated to
ensure both permissive foetal development through
endochondral ossification and postnatal longitudinal
growth at the epiphyseal growth plate. Tighter manage-
ment of these dynamic events may contribute to the
inherent stability of some cartilage, such as articular
cartilage, and this possibility is supported by emerging
evidence reporting the aberrant redeployment of these
transient events in the inherently stable cartilage in
several pathological states such as osteoarthritis. It is
therefore plausible that lessons can be realised from the
molecular mechanisms underpinning the physiological
transient chondrocyte differentiation and function. This
knowledge may help to decipher those mechanisms
surrounding joint pathology and ossification, and aid
future research into effective disease-modifying therapies.In this review, we discuss aspects of cartilage and bone
physiology, as well as the complex cellular processes
involved in the cartilage to bone transition during
endochondral ossification and at the postnatal growth
plate. Moreover, we will compare this transient cartilage
phenotype with the stable phenotype adopted by articular
chondrocytes in order to ostensibly safeguard their
permanence, and will discuss disease pathology in which
the aberrant redeployment of the transient phenotype
is observed.Transient cartilage
During mammalian embryological skeletal development,
the appendicular skeleton comprising the pectoral girdle,
pelvis and the limbs, arises from the lateral plate
mesoderm (Saito et al. 2006). These structures are formedsed under a Creative Commons
nported License.
 from Bioscientifica.com at 01/24/2020 02:11:45PM
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219 :1 R2by means of endochondral ossification as does much of
the axial skeleton including the vertebrae and ribs, which
arise from somites of paraxial mesoderm origin.
Ossification processes are regulated during embryolo-
gical development to produce the wide range of skeletal
forms that we see in different animal species. A major
challenge in skeletal morphogenesis is the precision of
growth regulation that is required to create functional
skeletal proportions, which can vary so widely between
species, and to produce paired skeletal elements which are
near identical in size. Therefore, there are major questions
in embryological skeletal development, including how do
condensations get to be the correct size and how is
directional growth achieved in limb patterning?
The apical ectodermal ridge and the zone of polarising
activity control proximo–distal and anterior–posterior
patterning in the growing limb bud. These two centres
are regulated by signalling pathways such as Indian
hedgehog (IHH) and WNT/b-catenin (reviewed elsewhere;
Summerbell et al. (1973), Kronenberg (2003), Tickle
(2003), Towers & Tickle (2009) and Wolpert (2010)).
Recent emerging evidence has suggested that planar cell
polarity, a non-canonical WNT pathway involving the
cadherins Fat and Dachsous (Fat/Dchs), is also important
in embryonic skeletal development (Goodrich & Strutt
2011). Gradients of Dchs expression appear to regulate cell
shape and directional movement during limb morpho-
genesis and growth (Dabdoub et al. 2003, Vladar et al.
2009, Wada & Okamoto 2009, Romereim & Dudley 2011).
There is also substantial evidence, from pharmacological
immobilisation of embryonic chicks, that movement-
induced mechanical bone loading regulates longitudinal
growth of skeletal elements (Osborne et al. 2002, Lamb
et al. 2003, Pitsillides 2006). Thus, mechanical stimuli may
exert epigenetic control over skeletal development to act
as an additional source of phenotypic variation during
development.Endochondral ossification
The majority of the skeleton is first formed during
embryonic development as cartilage anlagen; models of
future skeletal elements. The transient nature of this
cartilage is reflected in its eventual replacement by bone in
the fundamental process of endochondral ossification.
Endochondral ossification is initiated by embryonic
mesenchymal cells migrating to form pre-cartilage con-
densations, which then undergo differentiation into
chondrocytes and secrete an extracellular matrix rich in
collagen type II and aggrecan. The chondrocytes of thesehttp://joe.endocrinology-journals.org
DOI: 10.1530/JOE-13-0276
 2013 The authors
Printed in Great Britaincartilage condensations undergo an ordered and highly
regulated process involving predominant marginal
proliferation and central maturation, hypertrophy and
cell death. These latter events define the framework of the
endochondral bone and are regulated by paracrine signals
including parathyroid hormone (PTH)-related peptide and
IHH from the perichondrium (Fig. 1; Storm & Kingsley
1996, Tickle & Mu¨nsterberg 2001, Wang et al. 2001,
Kronenberg 2003, Davey et al. 2006, Villavicencio-Lorini
et al. 2010, Mackie et al. 2011).
Primary ossification originates in the centre of the
diaphysis of the developing skeletal element. The growth
cartilage is invaded by blood vessels, seemingly attracted
by VEGF expression by hypertrophic chondrocyte (Zelzer
et al. 2002) and with this, infiltration of bone-resorbing
osteoclasts and bone-forming osteoblasts occurs. Further-
more, the perichondrium becomes vascularised around
the bone-forming element to create the periosteum. This
process of blood vessel invasion facilitated by degradation
of the calcified cartilage extracellular matrix around the
hypertrophic chondrocytes is critically reliant on the
activity of matrix metalloproteinase 13 (MMP13; Stickens
et al. 2004). Cartilage matrix resorption is followed by the
invasion of osteoblasts, which lay down the newly formed
bone. This process spreads longitudinally from the
primary ossification centre towards the ends of the bone.
Eventually, a secondary ossification centre forms, retain-
ing a cartilaginous growth plate between each epiphysis
and the primary ossification centre (Mackie et al. 2008).Morphology of the postnatal growth plate
The growth plate is a highly specialised developmental
region, responsible for postnatal linear bone growth. It
consists of chondrocytes, arranged in columns that
parallel the axis of the bone, surrounded by their matrix;
the precise composition of which is dependent upon the
state of chondrocyte differentiation (Fig. 1; Ballock &
O’Keefe 2003, Mackie et al. 2011). These chondrocytes
undergo a series of tightly regulated differentiation and
maturation processes, as is reflected by their changing
morphology and matrix production, whilst maintaining
their spatially fixed locations (Hunziker et al. 1987).
Interference with the maturational progression of
growth plate chondrocytes leads to abnormal cartilage
formation and ossification and modifications in the rates
of bone formation, for example, in rickets and dwarfism.
Details of the many syndromes and diseases and possible
therapeutic strategies are out with the scope of this reviewPublished by Bioscientifica Ltd
Downloaded from Bioscientifica.com at 01/24/2020 02:11:45PM
via free access
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Figure 1
Schematic representation depicting the proposed developmental origins of
articular and growth plate cartilage. Mesenchymal aggregation of
chondro-progenitors forms the cartilage anlagen and stages of chondro-
cyte proliferation (P, light blue), maturation (M, purple) and hypertrophy
(H, pink) emerge to provide the origins of the future ‘transient’
chondrocytes of the growth plate cartilage. Intervening regions of
progressively condensing mesenchyme define the interzone (I, yellow)
regions; the position of the future joint and origins of the ‘stable’ articular
cartilage chondrocytes. Images (right hand side) depicting the organisation
of the mature growth plate (lower) and articular cartilage (upper),
consisting of uncalcified cartilage zones (superficial (SZ), intermediate (IZ)
and deep (DZ)), and the related chondrocyte and collagen fibril
arrangement. The tidemark separates the non-calcified cartilage from
the calcified cartilage (CC) which overlies the subchondral bone (SB).
BarZ0.1 mm.
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219 :1 R3but have been the subject of discussion in other reviews
(Kornak & Mundlos 2003, Krakow & Rimoin 2010).
The primary zone of the growth plate, often known as
the ‘resting’ or ‘germinal’ zone, consists of undifferen-
tiated chondrocyte progenitors. Unlike the remainder of
the growth plate, the chondrocytes of the resting zone are
distributed sporadically and have a low rate of prolifer-
ation (Hunziker et al. 1987, Ballock & O’Keefe 2003,
Mackie et al. 2011). As chondrocytes progress from the
resting zone, they gain a proliferative phenotype and
adopt a flattened, oblate shape, arranging themselves into
longitudinal columns. It is proposed that the creation of
these highly organised columns is directed by the
chondrocytes in the resting zone, which have been
postulated to produce a growth plate-orientating factorhttp://joe.endocrinology-journals.org
DOI: 10.1530/JOE-13-0276
 2013 The authors
Printed in Great Britain(Hunziker et al. 1987, Abad et al. 2002). The high mitotic
activity of these proliferating chondrocytes is controlled
by numerous factors, including endocrine/autocrine
regulation, circadian rhythm and age. These chondrocytes
also undergo a period of high secretory activity as they
produce a collagen type-II- and proteoglycan-rich
matrix, which with some otherwise marked distinctions
closely resembles that seen in the articular cartilage
(Farnum et al. 2002).
The chondrocytes undergo major phenotypic changes
as they gradually become hypertrophic however, until
recently the mechanisms by which this occurs is unclear
but may involve membrane transporters in the chondro-
cyte membrane (Bush et al. 2008, 2010, Loqman et al.
2013). Furthermore, a paper by Cooper et al. has definedPublished by Bioscientifica Ltd
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219 :1 R4three distinct phases through which mammalian chon-
drocyte volume increases: i) true hypertrophy, indicating a
proportionate increase in dry mass production and fluid
uptake, responsible for approximately threefold increases
in volume, ii) a fourfold enlargement solely by cell
swelling and iii) a second distinct phase of true hyper-
trophy with proportionate dry mass and fluid volume
increases. These authors show that this final stage is
dependent upon insulin-like growth factor 1 (IGF1), a
well-recognised regulator of longitudinal bone growth and
chondrocyte hypertrophy (Wang et al. 1999, Ahmed &
Farquharson 2010, Cooper et al. 2013, Farquharson &
Ahmed 2013). More recent emerging evidence has detailed
the regulation of IGF1 signalling in chondrocyte hyper-
trophy by the WNT signalling pathway, more specifically
by WNT-induced secreted protein 3 (Rao et al. 2013).
Indeed, it appears that the WNT pathway is critical in
both growth plate and articular cartilage function, as we
have previously discussed in our recent review (Staines
et al. 2012a).
As well as changes in cell morphology, collagen type-II
expression decreases during chondrocyte maturation and
the hypertrophic chondrocyte initiates the synthesis of
collagen type-X (Schmid & Linsenmayer 1985, Kronen-
berg 2003). The matrix also includes chondrocalcin,
osteonectin and osteopontin, as well as having increased
membrane activity of alkaline phosphatase, indicating the
final maturation phase (Sommer et al. 1996, Shen 2005,
Roberts et al. 2007). Together these changes facilitate
mineralisation of the matrix, a complex process reliant
upon the levels of calcium and phosphate (Castagnola
et al. 1988). Mineralisation of the extracellular matrix also
enables vascular invasion, through which osteoclasts and
osteoblasts gain access via migration to replace the
cartilage template with bone (Gerber et al. 1999, Horner
et al. 1999, Engsig et al. 2000, Zelzer et al. 2002). Recent
evidence has suggested that the terminally differentiated
hypertrophic chondrocyte may sense signals that initiate
this transformation of the cartilage matrix into bony
trabeculae through the expression of receptor activator
of nuclear factor-kB ligand, an essential cytokine for
osteoclast development, function and survival (Xiong
et al. 2011).
The fate of the terminally differentiated chondrocyte
at the chondro-osseous junction is still a matter of debate.
However, it is well accepted that this chondrocyte does
require to be removed so as to maintain the steady-state
thickness of the growth plate. There has been significant
evidence to suggest that the chondrocytes die by
apoptosis and this appears the most accepted mechanismhttp://joe.endocrinology-journals.org
DOI: 10.1530/JOE-13-0276
 2013 The authors
Printed in Great Britain(Magne et al. 2003, Shapiro et al. 2005). Indeed the
activation of caspases and the decreased expression of
the anti-apoptotic factor, Bcl2, in the hypertrophic
chondrocytes certainly support this (Amling et al. 1997,
Adams & Shapiro 2002). The distinct lack of typical
apoptotic morphological changes in the terminal hyper-
trophic chondrocytes does, however, challenge this theory
(Emons et al. 2009, Carames et al. 2010). It would be
expected that the condensation of cellular chromatin and
the fragmentation of the cell nucleus would be visible,
associated with the eventual break down of the cell into
several vesicles which are then phagocytosed. Instead, the
presence of autophagic vacuoles and the expression of
autophagy-regulating genes by growth plate chondrocytes
suggest that these cells undergo processes more similar to
autophagy than apoptosis (Roach & Clarke 2000, Shapiro
et al. 2005). Furthermore, the transdifferentiation of
chondrocytes has also been proposed (Descalzi Cancedda
et al. 1995, Roach 1997). This involves the division of the
terminal hypertrophic chondrocyte to produce one
daughter cell which undergoes apoptosis and one which
transdifferentiates into an osteoblast phenotype. However
this theory has yet to be fully ratified and would certainly
benefit from experiments which use GFP-Cre systems to
track the collagen type-X expression of the hypertrophic
chondrocyte during its terminal fate.
Longitudinal bone growth occurs at the growth plate
until it closes once sexual maturity has been reached. This
is initiated through the formation of mineralised tethers
between epiphyseal and diaphyseal bone promoting the
fusion of the primary and secondary ossification centres
(Haines 1975). The chondrocytes of the growth plate reach
a state of senescence as they exhaust their proliferative
potential, and longitudinal bone growth is ceased. In
humans, oestrogen mediates these effects in both males
and females and the processes controlling fusion are
relevant to understanding the ‘permanent’ loss of this
transient chondrocyte phenotype (Nilsson et al. 2005,
Mackie et al. 2011).Stable cartilage
Articular cartilage formation
The earliest emergence of ‘stable’, articular cartilage
during skeletal patterning occurs with the formation of
interzones; regions of undifferentiated mesenchyme
which separate developing skeletal elements in which
the joint will later form. There has been some debate as to
whether individual skeletal elements are discrete from thePublished by Bioscientifica Ltd
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form from a single cartilage condensation which is later
divided by interzones (Fig. 1; Pitsillides & Ashhurst 2008).
Transient growth cartilage and articular cartilage differ
in their collagen composition during their development;
in embryonic growth cartilage, expression of collagen
type-IIA precedes collagen type-IIB expression, which is
not detectable at later stages of development. However in
articular cartilage, collagen type-IIA protein does not
appear in the interzones, which provides evidence for
the belief that the cartilage anlagen that form individual
skeletal elements are not continuous (Ng et al. 1993,
Pitsillides & Ashhurst 2008). This suggests that the
populations of cells which will become the growth and
articular cartilage chondrocytes are discrete. Evidence for
these discrete origins is also provided by the GDF5-
mediated tracking of interzonal cells, and by the unique
expression of versican, an extracellular matrix proteogly-
can, in the regions of the presumptive articular cartilage in
joint morphogenesis (Pacifici et al. 2005, 2006, Snow et al.
2005, Hyde et al. 2007).
Interzones first appear as densely cellular, hom-
ogenous regions with GDF5, WNT9A, autotaxin and
chordin being known as interzone markers (Pacifici et al.
2005). Non-canonical WNT9A signalling is particularly
important early in development as it acts to inhibit
chondrocyte differentiation at the presumptive joint site
(Hartmann & Tabin 2001). As joint development pro-
gresses, the interzone differentiates into three recognisable
layers: two chondrogenic layers which cover the articular
surfaces of the developing opposed skeletal elements and
an intermediate layer which separates them. There is
evidence to suggest that the cells derived from this
intermediate layer differentiate to become articular chon-
drocytes, while the outer layer chondrocytes are incorpor-
ated into the growing epiphysis (Ito & Kida 2000).
Joint cavity formation is thought to occur due to a
combination of extrinsic mechanical factors and intrinsic
factors. Cell death is not thought to be primarily
responsible for the formation of the joint cleft; rather,
changes in extracellular matrix composition including
hyaluronan synthesis, mediated by mechanical activation
of the MEK–ERK pathway, which result in a loss of tissue
cohesion have been implicated (Archer et al. 1994, Ito &
Kida 2000, Bastow et al. 2005).Articular cartilage phenotype
Fully developed uncalcified articular cartilage can be
divided into superficial, intermediate and deep zoneshttp://joe.endocrinology-journals.org
DOI: 10.1530/JOE-13-0276
 2013 The authors
Printed in Great Britain(Fig. 1). These different zones consist of just one cell
type, the chondrocyte. These chondrocytes differ from the
transient growth plate chondrocytes as they maintain a
stable phenotype characterised by small cell size and
expression of tenascin-C, and they do not undergo a
sequence of proliferation, maturation, hypertrophy,
apoptosis and ossification (Pacifici et al. 2005, 2006). It
has been suggested that the expression of the transcription
factor ETS-related gene (ERG) is necessary early in joint
development to establish the articular chondrocyte
phenotype (Pacifici et al. 2006). It is the organisation of
cells and their collagen type-II and aggrecan-richmatrix in
the differing zones, however, which makes them distinct
from one another. Whilst the superficial zone consists of
elongated chondrocytes orientated parallel to the surface
of the cartilage, chondrocytes in the deep zone are more
rounded and aligned along the collagen fibrils. The
collagen fibrils in the intermediate zone of the articular
cartilage are arranged in arches which allow the transition
from thedeep and superficial zones (Minns&Steven1977).
The deep zone of the articular cartilage forms an
interface, termed the tidemark, with calcified cartilage
which forms through mechanisms that are not quite
understood. Within this calcified cartilage, the chondro-
cytes are hypertrophic and this is accompanied by their
expression of collagen type-X and alkaline phosphatase
(Heinegard & Oldberg 1989, Gannon et al. 1991, Stephens
et al. 1992). Therefore, despite the cellular singularity and
stability of the articular cartilage chondrocyte, there is
some degree of transiency due to the varying chondrocyte
phenotypes which exist within the entirety of the tissue.
This notion is supported by the presence of chondrocyte
progenitors in the superficial zone both at young stages
of development and in the mature cartilage (Dowthwaite
et al. 2004). Therefore tighter management of these
dynamic events, although much slower than those in
the growth plate, may alone underpin the maintenance of
the articular cartilage stability.
The calcified cartilage layer is semipermeable and
whilst it acts as a physical barrier for vascular invasion of
the overlying articular cartilage, it does permit the passage
of small molecules from the underlying subchondral bone
(Arkill &Winlove 2008). In humans, the calcified cartilage
thickness varies widely, fromw20 to 250 mmhowever, like
the tidemark, this a dynamic structure which can be
remodelled during ageing and disease, as highlighted
by observed morphological changes in osteoarthritis
including tidemark duplication and increased calcified
cartilage thickness (Lane & Bullough 1980, Oettmeier et al.
1989, Oegema et al. 1997, Hunziker et al. 2002, Burr 2004).Published by Bioscientifica Ltd
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osteochondral interface are yet to be fully defined. Their
identification may provide potential targets for thera-
peutic intervention.The ectopic initiation of cartilage–bone
transitions
The transition of cartilage to bone in the healthy
individual is under tight regulation so as to prevent
disturbed development and/or longitudinal bone growth.
Observations from disorders such as hypothyroidism,
rickets and dwarfism may provide insights into the
mechanisms underpinning defective hypertrophic differ-
entiation and ossification (Combs et al. 2011, Santos et al.
2013). Regulation is also observed in repair of fractured
bone tissue, in which there is a deliberate re-initiation of
the endochondral processes (see above) previously dis-
cussed in this review. There has been much recent focus
upon the WNT signalling pathway in fracture repair and,
in particular, the recent discovery of enhanced repair
through the administration of neutralizing antibodies
against sclerostin, a known WNT inhibitor (Secreto et al.
2009, Ominsky et al. 2011, Virk et al. 2013). In contrast to
this desired acceleration in endochondral ossification
processes, in certain diseases the ectopic redeployment
of these processes is detrimental and considered to be
at least contributory to the observed disease pathology.
Herein we discuss conditions in which this occurs and
touch upon current understanding regarding the role of
these processes in their aetiology.Osteoarthritis
Osteoarthritis is a degenerative joint disease and a massive
world-wide healthcare burden. Characterised by articular
cartilage loss, subchondral bone thickening and osteo-
phyte formation, the osteoarthritic joint afflicts much
pain and disability on its sufferers. Its underpinning
molecular mechanisms are, nevertheless, not fully under-
stood; indeed it is even still a matter of debate as to which
is the preceding pathology. However, there is increasing
evidence implicating the re-initiation of the transient
chondrocyte phenotype in osteoarthritic aetiology and
pathology (Fosang & Beier 2011, Pitsillides & Beier
2011; Fig. 2). This notion is based upon the previously
discussed common embryonic development of cartilage
and bone and the current evidence certainly merits
thorough examination. However, it has been met
with some controversy in the field (Brew et al. 2010).http://joe.endocrinology-journals.org
DOI: 10.1530/JOE-13-0276
 2013 The authors
Printed in Great BritainSuch controversies may potentially be addressed through a
better understanding of the articular cartilage volume to
surface area ratios in different species, and thus may
provide some explanation as to why the degree of
chondrocyte transiency in the articular cartilage differs
from species to species.
In osteoarthritic cartilage, there have been observed
decreases in collagen type-II and aggrecan integrity in
comparison to normal articular cartilage (Helminen et al.
1993, Garnero et al. 2002, Jalba et al. 2011, Henrotin et al.
2013). Furthermore, markers previously thought to be
unique to the hypertrophic chondrocytes of the growth
plate have been detected in the uncalcified articular
cartilage in both animal models of osteoarthritis, and in
patients with the disease. The best recognised of these are
MMP13 and collagen type-X, however, also detected are
alkaline phosphatase, osteopontin, IHH and osteocalcin
(Hoyland et al. 1991, Aigner et al. 1993, Pullig et al. 2000,
Appleton et al. 2007, Studer et al. 2012). As in the transient
growth plate cartilage, chondrocyte hypertrophy is
considered to be a prerequisite for matrix mineralisation
and in osteoarthritis, the increased formation of hydro-
xyapatite has been documented and is consistent with
hypertrophic chondrocyte changes (Fuerst et al. 2009).
MMP13, a key marker of chondrocyte hypertrophy, is
proving a critical target in osteoarthritis research due to
its potent role in the degradation of collagen type-II,
proteoglycans, collagen types-IV and IX, osteonectin and
perlecan (Wang et al. 2013). Indeed, Mmp13-deficient
mice predictably have an endochondral bone growth
defect with an expanded hypertrophic chondrocyte zone
which was not attributable to increased chondrocyte
proliferation, increased proteoglycan turnover and
increased trabecular bone (Stickens et al. 2004). Never-
theless, whilst the surgical induction of osteoarthritis in
this mouse causes chondrocyte hypertrophy and osteo-
phyte formation, the graded score of cartilage degradation
was intriguingly significantly reduced (Little et al. 1999).
Deletion of the Mmp13 gene specifically in chondrocytes
also produces similar deceleration of osteoarthritis disease
progression following meniscal-ligamentous injury in a
mouse model (Wang et al. 2013). Consistent with this
crucial role for Mmp13, its overexpression was also found
to result in pathological osteoarthritis-like changes in the
articular cartilage of mice (Neuhold et al. 2001). Recent
research has implicated the WNT signalling pathway and
its inhibitors as important regulators of MMP13 (van den
Bosch et al. 2013, Chan et al. 2013, Staines et al. 2013),
which is consistent with critical WNT function in thePublished by Bioscientifica Ltd
Downloaded from Bioscientifica.com at 01/24/2020 02:11:45PM
via free access
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Figure 2
Schematic diagram depicting the healthy articular joint and the
osteoarthritic joint in which articular cartilage fibrillation and degradation
is observed with concomitant subchondral bone thickening. Contributing
to this osteoarthritic pathology, the normally ‘stable’ articular chondro-
cytes of the articular cartilage adopt a ‘transient’ phenotype with observed
chondrocyte hypertrophy and matrix mineralisation similar to that seen
in the growth cartilage depicted in Fig. 1. Potential regulation of these
processes may include changes in the expression of matrix factors
(blue box; factors induced in osteoarthritis development in black, factors
lost in red), signalling pathways affecting chondrocyte phenotype and
function (yellow box) and the known regulators of mineralisation
processes (purple box) (Grover & Roughley 1993, Pacifici et al. 2006, Zhang
et al. 2007, Fosang & Beier 2011, Pitsillides & Beier 2011, Staines et al.
2012b). Lessons may be learnt from these and their application may better
identify disease aetiology.Jo
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Miclea et al. 2011).
Epigenetics has been strongly implicated in osteo-
arthritis in recent years with all three currently known
mechanisms – DNA methylation, histone modifications
and non-coding RNAs – demonstrate a capacity to control
the chondrocyte phenotype. This too has highlighted a
role for MMP13. More specifically, MMP13 promotor
methylation is altered in osteoarthritic cartilage,
suggesting that these epigenetic changes can therefore
drive the chondrocyte hypertrophy observed in the
pathological state (Roach et al. 2005). It should be noted
that the precise initiation and control of these events is yet
to be established. However, with the surge in epigenetic
studies in recent years, it is certainly an exciting and
promising time for this field.
This evidence therefore pinpoints the need to deci-
pher the molecular mechanisms underpinning the
recapitulation of some of these developmental ‘hallmarks’
by articular cartilage chondrocytes in osteoarthritis. It ishttp://joe.endocrinology-journals.org
DOI: 10.1530/JOE-13-0276
 2013 The authors
Printed in Great Britainenvisaged that this will undoubtedly advance under-
standing into disease pathology and might ultimately
define whether the pathogenic pathways in osteoarthritis
can be prevented by regulating the stability of chondro-
cytes by limiting acquisition of their transient, growth-
related phenotype.
Certainly the field of tissue engineering would benefit
from such understanding. Combining the use of cells and
biomaterials, this approach has emerged as a promising
target for cartilage repair. The first repair of cartilage
defects was described in 1994 and used autologous
chondrocytes (Brittberg et al. 1994). Despite the limi-
tations associated with this, including the need to disrupt
healthy cartilage and problems with culturing chondro-
cytes, its emergence has certainly set the platform from
which cartilage tissue engineering has greatly progressed
in recent years. The use of human mesenchymal stem
cells, with their ability to overcome the limitations
defined by the use of chondrocytes, has been repeatedly
reported in osteoarthritis as a means of providing promisePublished by Bioscientifica Ltd
Downloaded from Bioscientifica.com at 01/24/2020 02:11:45PM
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et al. 2010). It has become apparent that human
mesenchymal stem cells can also gain expression of the
chondrocyte hypertrophy marker, collagen type-X, and
it is clear that this still limits their effectiveness as a
candidate for tissue engineering. Indeed, a recent study
has shown that mesenchymal stem cells express higher
levels of the genes associated with osteoarthritis, upon
culture, than do chondrocytes derived from the osteo-
arthritic joints themselves (Mwale et al. 2010, Fernandes
et al. 2013).Intervertebral disc calcification
Intervertebral disc (IVD) degeneration is a major cause of
back pain worldwide with complex, expensive surgery
which is often prone to failure (Urban & Roberts 1995).
Located between the vertebral bodies of the spine, the
cartilaginous IVD functions to resist compressive loads
(Broberg 1983). Anatomically, it consists of a central
nucleus pulposus contained within a fibrocartilage ring,
the annulus fibrosus, laterally and the cartilage end plates
inferiorly and superiorly (Roberts et al. 2006). The nucleus
pulposus shares many similarities with articular cartilage,
both in its matrix composition and its cellular metabolism
(Raj 2008). Associated with ageing and with abnormal
mechanical loading playing a substantial role, the
pathogenesis of IVD degeneration is yet to be fully
elucidated. There is, however, emerging evidence for the
occurrence of hypertrophic differentiation in this process.
The IVDs of patients with degenerative disc disease
have increased alkaline phosphatase activity, and also in
contrast to healthy IVDs express significant levels of
hypertrophic differentiation markers, including collagen
type-X, osteoprotegerin (OPG), MMP13 and RUNX2 (Boos
et al. 1997, Nerlich et al. 1997, Sato et al. 2008, Rutges et al.
2010, Hristova et al. 2011). Associated with this, microCT
analysis clearly shows increased levels of IVD calcification
with increasing degeneration (Rutges et al. 2010). A recent
in vitro study has sought to examine the mineralisation
potential of the cells of the annulus fibrosus, and
concluded that under certain conditions these cells can
induce mineralisation, as indicated by their increased von
Kossa staining, alkaline phosphatase, MMP13 and RUNX2
expression (Nosikova et al. 2013).
Understanding of the mechanisms supporting
induction of such hypertrophy in IVD cells is somewhat
lacking. However, it was shown recently that PTH can
enhance disc repair through its inhibition of collagen
type-X and alkaline phosphatase expression, and throughhttp://joe.endocrinology-journals.org
DOI: 10.1530/JOE-13-0276
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Printed in Great Britainthe promotion of collagen type-II production. These
regenerative properties of PTH are mediated through
MAPK signalling (Madiraju et al. 2013). The authors of
this study suggest that PTH supplementation may prevent
further calcification in degenerated discs and potentially
enhance other cell-based therapies. This is certainly
promising due to the known critical role for PTH
signalling in chondrocyte hypertrophy and matrix min-
eralisation (Mackie et al. 2011, Yano et al. 2013). The
current major problem hindering IVD tissue engineering,
like in osteoarthritis, is the undesirable expression of
collagen type-X by human mesenchymal stem cells.
Recent studies have highlighted that PTH treatment can
also inhibit such misexpression and may thus open
additional avenues for the treatment of degenerative
IVDs with mesenchymal stem cells (Mwale et al. 2010).Heterotopic ossification
Heterotopic ossification (HO) is a common occurrence in
muscle, tendon and ligaments following trauma by injury,
disease or surgery. Initiated by cartilage formation, the
endochondral ossification and ectopic bone formation in
these tissues can produce severe functional impairment
(Medici & Olsen 2012).
Besides the trauma-induced HO described, a rare
disease called fibrodysplasia ossificans progressiva (FOP)
is a hereditary form of HO, presenting itself as painful and
highly inflammatory soft tissue swellings which pro-
gressively ossify rendering the sufferer immobile (Cohen
et al. 1993, Shore et al. 2006, Medici & Olsen 2012). Like
in trauma-induced HO, the aberrant bone formation in
patients with FOP occurs by means of endochondral
ossification processes. Emerging evidence has strongly
implicated increased bone morphogenetic protein (BMP)
signalling in the pathogenesis of FOP, as well as in trauma-
induced HO (Cohen et al. 1993, Kwapisz et al. 2013). The
identification of ACVR1/ALK2, one of the four type-I
receptors that mediate BMP signalling, as the mutated
gene in FOP in 2006 has further highlighted the BMP
signalling pathway as an attractive target for future
therapy (Shore et al. 2006).Conclusions
The aberrant redeployment of embryonic processes in
diseases such as osteoarthritis and IVD degeneration is
now well established. Emerging evidence has further
fuelled the hypothesis that lessons for limiting disease
progression can be acquired from the regulators ofPublished by Bioscientifica Ltd
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review provides some pointers as to potential targets for
future drug therapies or tissue engineering approaches
which will further our understanding of the underpinning
molecular mechanisms involved in these diseases, and will
provide advances towards patient benefit.Declaration of interest
The authors declare that there is no conflict of interest that could be
perceived as prejudicing the impartiality of the review.Funding
This work was supported by Arthritis Research UK (18768), the
Anatomical Society and an Institute Strategic Programme Grant from the
Biotechnology and Biological Sciences Research Council, UK (C F).Acknowledgements
The authors wish to acknowledge Arthritis Research UK, the Anatomical
Society and the BBSRC for funding.References
Abad V, Meyers JL, Weise M, Gafni RI, Barnes KM, Nilsson O, Bacher JD
& Baron J 2002 The role of the resting zone in growth plate
chondrogenesis. Endocrinology 143 1851–1857. (doi:10.1210/en.
143.5.1851)
Adams CS & Shapiro IM 2002 The fate of the terminally differentiated
chondrocyte: evidence for microenvironmental regulation of
chondrocyte apoptosis. Critical Reviews in Oral Biology and Medicine 13
465–473. (doi:10.1177/154411130201300604)
Ahmed SF & Farquharson C 2010 The effect of GH and IGF1 on linear
growth and skeletal development and their modulation by SOCS
proteins. Journal of Endocrinology 206 249–259. (doi:10.1677/
JOE-10-0045)
Aigner T, Reichenberger E, Bertling W, Kirsch T, Stoss H & von der Mark K
1993 Type X collagen expression in osteoarthritic and rheumatoid
articular cartilage. Virchows Archiv. B, Cell Pathology Including Molecular
Pathology 63 205–211. (doi:10.1007/BF02899263)
Amling M, Neff L, Tanaka S, Inoue D, Kuida K, Weir E, Philbrick WM,
Broadus AE & Baron R 1997 Bcl-2 lies downstream of parathyroid
hormone-related peptide in a signaling pathway that regulates
chondrocyte maturation during skeletal development. Journal of Cell
Biology 136 205–213. (doi:10.1083/jcb.136.1.205)
Appleton CT, Pitelka V, Henry J & Beier F 2007 Global analyses of gene
expression in early experimental osteoarthritis. Arthritis and
Rheumatism 56 1854–1868. (doi:10.1002/art.22711)
Archer CW, Morrison H & Pitsillides AA 1994 Cellular aspects of the
development of diarthrodial joints and articular cartilage. Journal of
Anatomy 184 447–456.
Arkill KP & Winlove CP 2008 Solute transport in the deep and calcified
zones of articular cartilage. Osteoarthritis and Cartilage 16 708–714.
(doi:10.1016/j.joca.2007.10.001)
Ballock RT & O’Keefe RJ 2003 Physiology and pathophysiology of the
growth plate. Birth Defects Research. Part C, Embryo Today: Reviews 69
123–143. (doi:10.1002/bdrc.10014)
Bastow ER, Lamb KJ, Lewthwaite JC, Osborne AC, Kavanagh E,
Wheeler-Jones CP & Pitsillides AA 2005 Selective activation of thehttp://joe.endocrinology-journals.org
DOI: 10.1530/JOE-13-0276
 2013 The authors
Printed in Great BritainMEK–ERK pathway is regulated by mechanical stimuli in forming
joints and promotes pericellular matrix formation. Journal of
Biological Chemistry 280 11749–11758. (doi:10.1074/jbc.
M414495200)
Boos N, Dreier D, Hilfiker E, Schade V, Kreis R, Hora J, Aebi M & Boesch C
1997 Tissue characterization of symptomatic and asymptomatic disc
herniations by quantitative magnetic resonance imaging. Journal of
Orthopaedic Research 15 141–149. (doi:10.1002/jor.1100150121)
van den Bosch M, Blom A, van Erp A, van de Loo F, Davidson EB,
van der Kraan P, van Lent P & van den Berg W 2013 Synovial Wnt and
Wisp1 expression induces expression of cartilage-degrading metallo-
proteinases in the synovium. Osteoarthritis and Cartilage 21 S284–S284.
(doi:10.1016/j.joca.2013.02.594)
Brew CJ, Clegg PD, Boot-Handford RP, Andrew JG & Hardingham T 2010
Gene expression in human chondrocytes in late osteoarthritis is
changed in both fibrillated and intact cartilage without evidence of
generalised chondrocyte hypertrophy. Annals of the Rheumatic Diseases
69 234–240. (doi:10.1136/ard.2008.097139)
Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O& Peterson L 1994
Treatment of deep cartilage defects in the knee with autologous
chondrocyte transplantation. New England Journal of Medicine 331
889–895. (doi:10.1056/NEJM199410063311401)
Broberg KB 1983 On the mechanical behaviour of intervertebral discs.
Spine 8 151–165. (doi:10.1097/00007632-198303000-00006)
Burr DB 2004 Anatomy and physiology of the mineralized tissues: role in
the pathogenesis of osteoarthrosis. Osteoarthritis and Cartilage
12(Suppl A) S20–S30. (doi:10.1016/j.joca.2003.09.016)
Bush PG, Parisinos CA&Hall AC 2008 The osmotic sensitivity of rat growth
plate chondrocytes in situ; clarifying the mechanisms of hypertrophy.
Journal of Cellular Physiology 214 621–629. (doi:10.1002/jcp.21249)
Bush PG, Pritchard M, Loqman MY, Damron TA & Hall AC 2010 A key role
for membrane transporter NKCC1 in mediating chondrocyte volume
increase in the mammalian growth plate. Journal of Bone and Mineral
Research 25 1594–1603. (doi:10.1002/jbmr.47)
Carames B, Taniguchi N, Otsuki S, Blanco FJ & Lotz M 2010 Autophagy is a
protective mechanism in normal cartilage, and its aging-related loss is
linked with cell death and osteoarthritis. Arthritis and Rheumatism 62
791–801. (doi:10.1002/art.27305)
Castagnola P, Dozin B, Moro G & Cancedda R 1988 Changes in the
expression of collagen genes show two stages in chondrocyte
differentiation in vitro. Journal of Cell Biology 106 461–467.
(doi:10.1083/jcb.106.2.461)
Chan BY, Ashton A, Smith MM & Little CB 2013 Sclerostin regulation of
Wisp1 and Mmps in chondrocytes is dependent on the Lrp5/6 binding
domain but not secretion from the cell. Osteoarthritis and Cartilage 21
S55–S55. (doi:10.1016/j.joca.2013.02.127)
Cohen RB, Hahn GV, Tabas JA, Peeper J, Levitz CL, Sando A, Sando N,
Zasloff M & Kaplan FS 1993 The natural history of heterotopic
ossification in patients who have fibrodysplasia ossificans progressiva.
A study of forty-four patients. Journal of Bone and Joint Surgery. American
Volume 75 215–219.
Coleman CM, Curtin C, Barry FP, O’Flatharta C & Murphy JM 2010
Mesenchymal stem cells and osteoarthritis: remedy or accomplice?
Human Gene Therapy 21 1239–1250. (doi:10.1089/hum.2010.138)
Combs CE, Nicholls JJ, Duncan Bassett JH & Williams GR 2011 Thyroid
hormones and bone development. Minerva Endocrinologica 36 71–85.
Cooper KL, Oh S, Sung Y, Dasari RR, Kirschner MW & Tabin CJ 2013
Multiple phases of chondrocyte enlargement underlie differences in
skeletal proportions. Nature 495 375–378. (doi:10.1038/nature11940)
Dabdoub A, Donohue MJ, Brennan A, Wolf V, Montcouquiol M,
Sassoon DA, Hseih JC, Rubin JS, Salinas PC & Kelley MW 2003 Wnt
signaling mediates reorientation of outer hair cell stereociliary bundles
in the mammalian cochlea. Development 130 2375–2384. (doi:10.1242/
dev.00448)
Davey MG, Paton IR, Yin Y, Schmidt M, Bangs FK, Morrice DR, Smith TG,
Buxton P, Stamataki D, Tanaka M et al. 2006 The chicken talpid3 genePublished by Bioscientifica Ltd
Downloaded from Bioscientifica.com at 01/24/2020 02:11:45PM
via free access
Jo
u
rn
a
l
o
f
E
n
d
o
cr
in
o
lo
g
y
Review K A STAINES and others Cartilage–bone transitions:
health and disease
219 :1 R10encodes a novel protein essential for Hedgehog signaling. Genes and
Development 20 1365–1377. (doi:10.1101/gad.369106)
Descalzi Cancedda F, Melchiori A, Benelli R, Gentili C, Masiello L,
Campanile G, Cancedda R & Albini A 1995 Production of angiogenesis
inhibitors and stimulators is modulated by cultured growth plate
chondrocytes during in vitro differentiation: dependence on extra-
cellular matrix assembly. European Journal of Cell Biology 66 60–68.
Dowthwaite GP, Bishop JC, Redman SN, Khan IM, Rooney P, Evans DJ,
Haughton L, Bayram Z, Boyer S, Thomson B et al. 2004 The surface of
articular cartilage contains a progenitor cell population. Journal of Cell
Science 117 889–897. (doi:10.1242/jcs.00912)
Emons J, Chagin AS, Hultenby K, Zhivotovsky B, Wit JM, Karperien M &
Savendahl L 2009 Epiphyseal fusion in the human growth plate does
not involve classical apoptosis. Pediatric Research 66 654–659.
(doi:10.1203/PDR.0b013e3181beaa8c)
Engsig MT, Chen QJ, Vu TH, Pedersen AC, Therkidsen B, Lund LR,
Henriksen K, Lenhard T, Foged NT, Werb Z et al. 2000 Matrix
metalloproteinase 9 and vascular endothelial growth factor are
essential for osteoclast recruitment into developing long bones.
Journal of Cell Biology 151 879–889. (doi:10.1083/jcb.151.4.879)
Farnum CE, Lee R, O’Hara K & Urban JP 2002 Volume increase in growth
plate chondrocytes during hypertrophy: the contribution of organic
osmolytes. Bone 30 574–581. (doi:10.1016/S8756-3282(01)00710-4)
Farquharson C & Ahmed SF 2013 Inflammation and linear bone growth:
the inhibitory role of SOCS2 on GH/IGF-1 signaling. Pediatric
Nephrology 28 547–556. (doi:10.1007/s00467-012-2271-0)
Fernandes AM, Herlofsen SR, Karlsen TA, Kuchler AM, Floisand Y &
Brinchmann JE 2013 Similar properties of chondrocytes from osteo-
arthritis joints and mesenchymal stem cells from healthy donors for
tissue engineering of articular cartilage. PLoS ONE 8 e62994.
(doi:10.1371/journal.pone.0062994)
Fosang AJ & Beier F 2011 Emerging frontiers in cartilage and chondrocyte
biology. Best Practice & Research. Clinical Rheumatology 25 751–766.
(doi:10.1016/j.berh.2011.11.010)
Fuerst M, Bertrand J, Lammers L, Dreier R, Echtermeyer F, Nitschke Y,
Rutsch F, Schafer FK, Niggemeyer O, Steinhagen J et al. 2009
Calcification of articular cartilage in human osteoarthritis. Arthritis and
Rheumatism 60 2694–2703. (doi:10.1002/art.24774)
Gannon JM, Walker G, Fischer M, Carpenter R, Thompson RC Jr &
Oegema TR Jr 1991 Localization of type X collagen in canine growth
plate and adult canine articular cartilage. Journal of Orthopaedic
Research 9 485–494. (doi:10.1002/jor.1100090404)
Garnero P, Ayral X, Rousseau JC, Christgau S, Sandell LJ, Dougados M &
Delmas PD 2002 Uncoupling of type II collagen synthesis and
degradation predicts progression of joint damage in patients with knee
osteoarthritis. Arthritis and Rheumatism 46 2613–2624. (doi:10.1002/
art.10576)
Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z & Ferrara N 1999 VEGF
couples hypertrophic cartilage remodeling, ossification and angiogen-
esis during endochondral bone formation. Nature Medicine 5 623–628.
(doi:10.1038/9467)
Goodrich LV & Strutt D 2011 Principles of planar polarity in animal
development. Development 138 1877–1892. (doi:10.1242/dev.054080)
Grover J & Roughley PJ 1993 Versican gene expression in human articular
cartilage and comparison of mRNA splicing variation with aggrecan.
Biochemical Journal 291 361–367.
Haines RW 1975 The histology of epiphyseal union in mammals. Journal of
Anatomy 120 1–25.
Hartmann C & Tabin CJ 2001 Wnt-14 plays a pivotal role in inducing
synovial joint formation in the developing appendicular skeleton.
Cell 104 341–351. (doi:10.1016/S0092-8674(01)00222-7)
Heinegard D & Oldberg A 1989 Structure and biology of cartilage and bone
matrix noncollagenous macromolecules. FASEB Journal 3 2042–2051.
Helminen HJ, Kiraly K, Pelttari A, Tammi MI, Vandenberg P, Pereira R,
Dhulipala R, Khillan JS, Ala-Kokko L, Hume EL et al. 1993 An inbred line
of transgenic mice expressing an internally deleted gene for type IIhttp://joe.endocrinology-journals.org
DOI: 10.1530/JOE-13-0276
 2013 The authors
Printed in Great Britainprocollagen (COL2A1). Young mice have a variable phenotype of a
chondrodysplasia and older mice have osteoarthritic changes in joints.
Journal of Clinical Investigation 92 582–595. (doi:10.1172/JCI116625)
Henrotin Y, Chevalier X, Deberg M, Balblanc JC, Richette P, Mulleman D,
Maillet B, Rannou F, Piroth C, Mathieu P et al. 2013 Early decrease of
serum biomarkers of type II collagen degradation (Coll2-1) and joint
inflammation (Coll2-1 NO2) by hyaluronic acid intra-articular
injections in patients with knee osteoarthritis: a research study part
of the Biovisco study. Journal of Orthopaedic Research 31 901–907.
(doi:10.1002/jor.22297)
Horner A, Bishop NJ, Bord S, Beeton C, Kelsall AW, Coleman N &
Compston JE 1999 Immunolocalisation of vascular endothelial growth
factor (VEGF) in human neonatal growth plate cartilage. Journal of
Anatomy 194 519–524. (doi:10.1046/j.1469-7580.1999.19440519.x)
Hoyland JA, Thomas JT, Donn R, Marriott A, Ayad S, Boot-Handford RP,
Grant ME& Freemont AJ 1991 Distribution of type X collagenmRNA in
normal and osteoarthritic human cartilage. Bone and Mineral 15
151–163. (doi:10.1016/0169-6009(91)90005-K)
Hristova GI, Jarzem P, Ouellet JA, Roughley PJ, Epure LM, Antoniou J &
Mwale F 2011 Calcification in human intervertebral disc degeneration
and scoliosis. Journal of Orthopaedic Research 29 1888–1895.
(doi:10.1002/jor.21456)
Hunziker EB, Schenk RK & Cruz-Orive LM 1987 Quantitation of
chondrocyte performance in growth-plate cartilage during longitudi-
nal bone growth. Journal of Bone and Joint Surgery. American Volume 69
162–173.
Hunziker EB, Quinn TM & Hauselmann HJ 2002 Quantitative structural
organization of normal adult human articular cartilage. Osteoarthritis
and Cartilage 10 564–572. (doi:10.1053/joca.2002.0814)
Hyde G, Dover S, Aszodi A, Wallis GA & Boot-Handford RP 2007 Lineage
tracing using matrilin-1 gene expression reveals that articular chon-
drocytes exist as the joint interzone forms. Developmental Biology 304
825–833. (doi:10.1016/j.ydbio.2007.01.026)
Ito MM & Kida MY 2000 Morphological and biochemical re-evaluation
of the process of cavitation in the rat knee joint: cellular and cell
strata alterations in the interzone. Journal of Anatomy 197 659–679.
(doi:10.1046/j.1469-7580.2000.19740659.x)
Jalba BA, Jalba CS, Vladoi AD, Gherghina F, Stefan E & Cruce M 2011
Alterations in expression of cartilage-specific genes for aggrecan and
collagen type II in osteoarthritis. Romanian Journal of Morphology and
Embryology 52 587–591.
Kornak U & Mundlos S 2003 Genetic disorders of the skeleton:
a developmental approach. American Journal of Human Genetics 73
447–474. (doi:10.1086/377110)
KrakowD& Rimoin DL 2010 The skeletal dysplasias. Genetics in Medicine 12
327–341. (doi:10.1097/GIM.0b013e3181daae9b)
Kronenberg HM 2003 Developmental regulation of the growth plate.
Nature 423 332–336. (doi:10.1038/nature01657)
Kwapisz A, Kozlowski P, Szemraj J, Synder M & Sibinski M 2013
Correlations between BMP-4 gene expression, heterotopic ossification
and function after uncemented total hip replacement. Ortopedia,
Traumatologia, Rehabilitacja 15 116–124. (doi:10.5604/15093492.
1045951)
Lamb KJ, Lewthwaite JC, Lin JP, Simon D, Kavanagh E,Wheeler-Jones CP &
Pitsillides AA 2003 Diverse range of fixed positional deformities and
bone growth restraint provoked by flaccid paralysis in embryonic
chicks. International Journal of Experimental Pathology 84 191–199.
(doi:10.1046/j.1365-2613.2003.00353.x)
Lane LB & Bullough PG 1980 Age-related changes in the thickness of the
calcified zone and the number of tidemarks in adult human articular
cartilage. Journal of Bone and Joint Surgery. British Volume 62 372–375.
Little CB, Flannery CR, Hughes CE, Mort JS, Roughley PJ, Dent C &
Caterson B 1999 Aggrecanase versus matrix metalloproteinases in the
catabolism of the interglobular domain of aggrecan in vitro. Biochemical
Journal 344 61–68. (doi:10.1042/0264-6021:3440061)Published by Bioscientifica Ltd
Downloaded from Bioscientifica.com at 01/24/2020 02:11:45PM
via free access
Jo
u
rn
a
l
o
f
E
n
d
o
cr
in
o
lo
g
y
Review K A STAINES and others Cartilage–bone transitions:
health and disease
219 :1 R11Loqman MY, Bush PG, Farquharson C & Hall AC 2013 Suppression of
mammalian bone growth by membrane transport inhibitors. Journal of
Cellular Biochemistry 114 658–668. (doi:10.1002/jcb.24408)
Luyten FP 2004 Mesenchymal stem cells in osteoarthritis. Current
Opinion in Rheumatology 16 599–603. (doi:10.1097/01.bor.
0000130284.64686.63)
Mackie EJ, Ahmed YA, Tatarczuch L, Chen KS & Mirams M 2008
Endochondral ossification: how cartilage is converted into bone in the
developing skeleton. International Journal of Biochemistry & Cell Biology
40 46–62. (doi:10.1016/j.biocel.2007.06.009)
Mackie EJ, Tatarczuch L &Mirams M 2011 The skeleton: a multi-functional
complex organ: the growth plate chondrocyte and endochondral
ossification. Journal of Endocrinology 211 109–121. (doi:10.1530/
JOE-11-0048)
Madiraju P, Gawri R, Wang H, Antoniou J & Mwale F 2013 Mechanism of
parathyroid hormone-mediated suppression of calcification markers in
human intervertebral disc cells. European Cells & Materials 25 268–283.
Magne D, Bluteau G, Faucheux C, Palmer G, Vignes-Colombeix C, Pilet P,
Rouillon T, Caverzasio J, Weiss P, Daculsi G et al. 2003 Phosphate is a
specific signal for ATDC5 chondrocyte maturation and apoptosis-
associated mineralization: possible implication of apoptosis in the
regulation of endochondral ossification. Journal of Bone and Mineral
Research 18 1430–1442. (doi:10.1359/jbmr.2003.18.8.1430)
Medici D &Olsen BR 2012 The role of endothelial–mesenchymal transition
in heterotopic ossification. Journal of Bone and Mineral Research 27
1619–1622. (doi:10.1002/jbmr.1691)
Miclea RL, Siebelt M, Finos L, Goeman JJ, Lowik CWGM, Oostdijk W,
Weinans H, Wit JM, Robanus-Maandag EC & Karperien M 2011
Inhibition of Gsk3b in cartilage induces osteoarthritic features through
activation of the canonical Wnt signaling pathway. Osteoarthritis and
Cartilage 19 1363–1372. (doi:10.1016/j.joca.2011.07.014)
Minns RJ & Steven FS 1977 The collagen fibril organization in human
articular cartilage. Journal of Anatomy 123 437–457.
Mwale F, Yao G, Ouellet JA, Petit A & Antoniou J 2010 Effect of parathyroid
hormone on type X and type II collagen expression in mesenchymal
stem cells from osteoarthritic patients. Tissue Engineering. Part A 16
3449–3455. (doi:10.1089/ten.tea.2010.0091)
Nerlich AG, Schleicher ED & Boos N 1997 1997 Volvo Award winner in
basic science studies. Immunohistologic markers for age-related
changes of human lumbar intervertebral discs. Spine 22 2781–2795.
(doi:10.1097/00007632-199712150-00001)
Neuhold LA, Killar L, ZhaoW, Sung ML, Warner L, Kulik J, Turner J, WuW,
Billinghurst C, Meijers T et al. 2001 Postnatal expression in hyaline
cartilage of constitutively active human collagenase-3 (MMP-13)
induces osteoarthritis in mice. Journal of Clinical Investigation 107
35–44. (doi:10.1172/JCI10564)
Ng LJ, Tam PP & Cheah KS 1993 Preferential expression of alternatively
spliced mRNAs encoding type II procollagen with a cysteine-rich
amino-propeptide in differentiating cartilage and nonchondrogenic
tissues during early mouse development. Developmental Biology 159
403–417. (doi:10.1006/dbio.1993.1251)
Nilsson O, Marino R, De Luca F, Phillip M & Baron J 2005 Endocrine
regulation of the growth plate. Hormone Research 64 157–165.
(doi:10.1159/000088791)
Nosikova Y, Santerre JP, Grynpas MD & Kandel RA 2013 Annulus fibrosus
cells can induce mineralization: an in vitro study. Spine Journal 13 443–
453. (doi:10.1016/j.spinee.2012.11.050)
Oegema TR Jr, Carpenter RJ, Hofmeister F & Thompson RC Jr 1997 The
interaction of the zone of calcified cartilage and subchondral bone in
osteoarthritis. Microscopy Research and Technique 37 324–332. (doi:10.
1002/(SICI)1097-0029(19970515)37:4!324::AID-JEMT7O3.0.CO;2-K)
Oettmeier R, Abendroth K & Oettmeier S 1989 Analyses of the tidemark on
human femoral heads. II. Tidemark changes in osteoarthrosis – a
histological and histomorphometric study in non-decalcified
preparations. Acta Morphologica Hungarica 37 169–180.http://joe.endocrinology-journals.org
DOI: 10.1530/JOE-13-0276
 2013 The authors
Printed in Great BritainOminsky MS, Li C, Li X, Tan HL, Lee E, Barrero M, Asuncion FJ, Dwyer D,
Han CY, Vlasseros F et al. 2011 Inhibition of sclerostin by monoclonal
antibody enhances bone healing and improves bone density and
strength of nonfractured bones. Journal of Bone and Mineral Research 26
1012–1021. (doi:10.1002/jbmr.307)
Osborne AC, Lamb KJ, Lewthwaite JC, Dowthwaite GP & Pitsillides AA
2002 Short-term rigid and flaccid paralyses diminish growth of
embryonic chick limbs and abrogate joint cavity formation but
differentially preserve pre-cavitated joints. Journal of Musculoskeletal &
Neuronal Interactions 2 448–456.
Pacifici M, Koyama E & IwamotoM 2005Mechanisms of synovial joint and
articular cartilage formation: recent advances, but many lingering
mysteries. Birth Defects Research. Part C, Embryo Today: Reviews 75
237–248. (doi:10.1002/bdrc.20050)
Pacifici M, Koyama E, Shibukawa Y, Wu C, Tamamura Y, Enomoto-
Iwamoto M & Iwamoto M 2006 Cellular and molecular mechanisms of
synovial joint and articular cartilage formation. Annals of the New York
Academy of Sciences 1068 74–86. (doi:10.1196/annals.1346.010)
Pitsillides AA 2006 Early effects of embryonic movement: ‘a shot out
of the dark’. Journal of Anatomy 208 417–431. (doi:10.1111/j.1469-
7580.2006.00556.x)
Pitsillides AA & Ashhurst DE 2008 A critical evaluation of specific aspects
of joint development. Developmental Dynamics 237 2284–2294.
(doi:10.1002/dvdy.21654)
Pitsillides AA & Beier F 2011 Cartilage biology in osteoarthritis – lessons
from developmental biology. Nature Reviews. Rheumatology 7 654–663.
(doi:10.1038/nrrheum.2011.129)
Pullig O, Weseloh G, Ronneberger D, Kakonen S & Swoboda B 2000
Chondrocyte differentiation in human osteoarthritis: expression of
osteocalcin in normal and osteoarthritic cartilage and bone. Calcified
Tissue International 67 230–240. (doi:10.1007/s002230001108)
Raj PP 2008 Intervertebral disc: anatomy-physiology-pathophysiology-
treatment. Pain Practice 8 18–44. (doi:10.1111/j.1533-2500.
2007.00171.x)
Rao RS, Patra M & Sen M 2013 WISP3–IGF1 interaction regulates
chondrocyte hypertrophy. Journal of Cell Science 126 1650–1658.
(doi:10.1242/jcs.119859)
Roach HI 1997 New aspects of endochondral ossification in the chick:
chondrocyte apoptosis, bone formation by former chondrocytes,
and acid phosphatase activity in the endochondral bone matrix.
Journal of Bone and Mineral Research 12 795–805. (doi:10.1359/
jbmr.1997.12.5.795)
Roach HI & Clarke NM 2000 Physiological cell death of chondrocytes
in vivo is not confined to apoptosis. New observations on the
mammalian growth plate. Journal of Bone and Joint Surgery. British
Volume 82 601–613. (doi:10.1302/0301-620X.82B4.9846)
RoachHI, YamadaN,Cheung KS, Tilley S, ClarkeNM,Oreffo RO, Kokubun S
& Bronner F 2005 Association between the abnormal expression of
matrix-degrading enzymes by human osteoarthritic chondrocytes and
demethylationof specificCpGsites in thepromoter regions.Arthritis and
Rheumatism 52 3110–3124. (doi:10.1002/art.21300)
Roberts S, Evans H, Trivedi J & Menage J 2006 Histology and pathology of
the human intervertebral disc. Journal of Bone and Joint Surgery. American
Volume 88(Suppl 2) 10–14. (doi:10.2106/JBJS.F.00019)
Roberts S, Narisawa S, Harmey D, Millan JL & Farquharson C 2007
Functional involvement of PHOSPHO1 in matrix vesicle-mediated
skeletal mineralization. Journal of Bone andMineral Research 22 617–627.
(doi:10.1359/jbmr.070108)
Romereim SM & Dudley AT 2011 Cell polarity: the missing link in skeletal
morphogenesis? Organogenesis 7 217–228. (doi:10.4161/org.7.3.18583)
Rutges JP, Duit RA, Kummer JA, Oner FC, van Rijen MH, Verbout AJ,
Castelein RM, Dhert WJ & Creemers LB 2010 Hypertrophic
differentiation and calcification during intervertebral disc
degeneration. Osteoarthritis and Cartilage 18 1487–1495. (doi:10.1016/
j.joca.2010.08.006)Published by Bioscientifica Ltd
Downloaded from Bioscientifica.com at 01/24/2020 02:11:45PM
via free access
Jo
u
rn
a
l
o
f
E
n
d
o
cr
in
o
lo
g
y
Review K A STAINES and others Cartilage–bone transitions:
health and disease
219 :1 R12Saito D, Yonei-Tamura S, Takahashi Y & Tamura K 2006 Level-specific role
of paraxial mesoderm in regulation of Tbx5/Tbx4 expression and limb
initiation. Developmental Biology 292 79–89. (doi:10.1016/j.ydbio.2006.
01.002)
Santos F, Fuente R, Mejia N, Mantecon L, Gil-Pena H & Ordonez FA 2013
Hypophosphatemia and growth. Pediatric Nephrology 28 595–603.
(doi:10.1007/s00467-012-2364-9)
Sato S, Kimura A, Ozdemir J, Asou Y, Miyazaki M, Jinno T, Ae K, Liu X,
Osaki M, Takeuchi Y et al. 2008 The distinct role of the Runx proteins
in chondrocyte differentiation and intervertebral disc degeneration:
findings in murine models and in human disease. Arthritis and
Rheumatism 58 2764–2775. (doi:10.1002/art.23805)
Schmid TM & Linsenmayer TF 1985 Developmental acquisition of type X
collagen in the embryonic chick tibiotarsus. Developmental Biology 107
373–381. (doi:10.1016/0012-1606(85)90319-7)
Secreto FJ, Hoeppner LH & Westendorf JJ 2009 Wnt signaling during
fracture repair. Current Osteoporosis Reports 7 64–69. (doi:10.1007/
s11914-009-0012-5)
Shapiro IM, Adams CS, Freeman T & Srinivas V 2005 Fate of the
hypertrophic chondrocyte: microenvironmental perspectives on
apoptosis and survival in the epiphyseal growth plate. Birth Defects
Research. Part C, Embryo Today: Reviews 75 330–339. (doi:10.1002/
bdrc.20057)
Shen G 2005 The role of type X collagen in facilitating and regulating
endochondral ossification of articular cartilage. Orthodontics & Cranio-
facial Research 8 11–17. (doi:10.1111/j.1601-6343.2004.00308.x)
Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho TJ, Choi IH,
Connor JM, Delai P, Glaser DL, LeMerrer M et al. 2006 A recurrent
mutation in the BMP type I receptor ACVR1 causes inherited
and sporadic fibrodysplasia ossificans progressiva. Nature Genetics 38
525–527. (doi:10.1038/ng1783)
Snow HE, Riccio LM, Mjaatvedt CH, Hoffman S & Capehart AA 2005
Versican expression during skeletal/joint morphogenesis and pattern-
ing of muscle and nerve in the embryonic mouse limb. Anatomical
Record. Part A, Discoveries in Molecular, Cellular, and Evolutionary Biology
282 95–105.
Sommer B, Bickel M, Hofstetter W & Wetterwald A 1996 Expression of
matrix proteins during the development of mineralized tissues. Bone 19
371–380. (doi:10.1016/S8756-3282(96)00218-9)
Staines KA, Macrae VE & Farquharson C 2012a Cartilage development and
degeneration: a Wnt Wnt situation. Cell Biochemistry and Function 30
633–642. (doi:10.1002/cbf.2852)
StainesKA,MacraeVE&FarquharsonC2012bThe importanceof theSIBLING
family of proteins on skeletal mineralisation and bone remodelling.
Journal of Endocrinology 214 241–255. (doi:10.1530/JOE-12-0143)
Staines KA, Poulet B, Farquharson C & Pitsillides AA 2013 The sclerostin
and Mepe axis in the development of osteoarthrttis. Osteoarthritis and
Cartilage 21 S55–S55. (doi:10.1016/j.joca.2013.02.128)
Stephens M, Kwan AP, Bayliss MT & Archer CW 1992 Human articular
surface chondrocytes initiate alkaline phosphatase and type X collagen
synthesis in suspension culture. Journal of Cell Science 103 1111–1116.
Stickens D, Behonick DJ, Ortega N, Heyer B, Hartenstein B, Yu Y, Fosang AJ,
Schorpp-Kistner M, Angel P &Werb Z 2004 Altered endochondral bone
development in matrix metalloproteinase 13-deficient mice. Develop-
ment 131 5883–5895. (doi:10.1242/dev.01461)
Storm EE & Kingsley DM 1996 Joint patterning defects caused by single and
double mutations in members of the bone morphogenetic protein
(BMP) family. Development 122 3969–3979.
Studer D, Millan C, Ozturk E, Maniura-Weber K & Zenobi-Wong M 2012
Molecular and biophysical mechanisms regulating hypertrophic
differentiation in chondrocytes and mesenchymal stem cells. European
Cells & Materials 24 118–135; discussion 135.http://joe.endocrinology-journals.org
DOI: 10.1530/JOE-13-0276
 2013 The authors
Printed in Great BritainSummerbell D, Lewis JH &Wolpert L 1973 Positional information in chick
limb morphogenesis. Nature 244 492–496. (doi:10.1038/244492a0)
Tickle C 2003 Patterning systems – from one end of the limb to the other.
Developmental Cell 4 449–458. (doi:10.1016/S1534-5807(03)00095-9)
Tickle C & Mu¨nsterberg A 2001 Vertebrate limb development – the early
stages in chick and mouse. Current Opinion in Genetics & Development 11
476–481. (doi:10.1016/S0959-437X(00)00220-3)
Towers M & Tickle C 2009 Generation of pattern and form in the
developing limb. International Journal of Developmental Biology 53
805–812. (doi:10.1387/ijdb.072499mt)
Urban JP & Roberts S 1995 Development and degeneration of the
intervertebral discs. Molecular Medicine Today 1 329–335. (doi:10.1016/
S1357-4310(95)80032-8)
Villavicencio-Lorini P, Kuss P, Friedrich J, Haupt J, Farooq M, Turkmen S,
Duboule D, Hecht J & Mundlos S 2010 Homeobox genes d11–d13 and
a13 control mouse autopod cortical bone and joint formation.
Journal of Clinical Investigation 120 1994–2004. (doi:10.1172/JCI41554)
Virk MS, Alaee F, Tang H, Ominsky MS, Ke HZ & Lieberman JR 2013
Systemic administration of sclerostin antibody enhances bone repair in
a critical-sized femoral defect in a rat model. Journal of Bone and Joint
Surgery. American Volume 95 694–701. (doi:10.2106/JBJS.L.00285)
Vladar EK, Antic D & Axelrod JD 2009 Planar cell polarity signaling: the
developing cell’s compass. Cold Spring Harbor Perspectives in Biology 1
a002964. (doi:10.1101/cshperspect.a002964)
Wada H & Okamoto H 2009 Roles of planar cell polarity pathway genes
for neural migration and differentiation. Development, Growth &
Differentiation 51 233–240. (doi:10.1111/j.1440-169X.2009.01092.x)
Wang J, Zhou J & Bondy CA 1999 Igf1 promotes longitudinal bone growth
by insulin-like actions augmenting chondrocyte hypertrophy. FASEB
Journal 13 1985–1990.
Wang Q, Green RP, Zhao G & Ornitz DM 2001 Differential regulation of
endochondral bone growth and joint development by FGFR1 and
FGFR3 tyrosine kinase domains. Development 128 3867–3876.
WangM, Sampson ER, Jin H, Li J, Ke QH, Im HJ & Chen D 2013MMP13 is a
critical target gene during the progression of osteoarthritis. Arthritis
Research & Therapy 15 R5. (doi:10.1186/ar4133)
Wolpert L 2010 Arms and the man: the problem of symmetric growth. PLoS
Biology 8 e1000477. (doi:10.1371/journal.pbio.1000477)
Xiong J, Onal M, Jilka RL, Weinstein RS, Manolagas SC & O’Brien CA 2011
Matrix-embedded cells control osteoclast formation.Nature Medicine 17
1235–1241. (doi:10.1038/nm.2448)
Yano F, Saito T, Ogata N, Yamazawa T, Iino M, Chung UI & Kawaguchi H
2013 b-Catenin regulates parathyroid hormone/parathyroid hormone-
related protein receptor signals and chondrocyte hypertrophy through
binding to the intracellular C-terminal region of the receptor. Arthritis
and Rheumatism 65 429–435. (doi:10.1002/art.37779)
Zelzer E, McLean W, Ng YS, Fukai N, Reginato AM, Lovejoy S, D’Amore PA
& Olsen BR 2002 Skeletal defects in VEGF(120/120) mice reveal
multiple roles for VEGF in skeletogenesis. Development 129 1893–1904.
ZhangY, Ryan JA,DiCesare PE, Liu J,WalshCA&YouZ 2007Doublecortin is
expressed in articular chondrocytes. Biochemical and Biophysical Research
Communications 363 694–700. (doi:10.1016/j.bbrc.2007.09.030)
ZhuM, ChenM, ZuscikM,WuQ,Wang YJ, Rosier RN, O’Keefe RJ &Chen D
2008 Inhibition of b-catenin signaling in articular chondrocytes
results in articular cartilage destruction. Arthritis and Rheumatism 58
2053–2064. (doi:10.1002/art.23614)
Zhu M, Tang DZ, Wu QQ, Hao SY, Chen M, Xie C, Rosier RN, O’Keefe RJ,
Zuscik M & Chen D 2009 Activation of b-catenin signaling in articular
chondrocytes leads to osteoarthritis-like phenotype in adult b-catenin
conditional activation mice. Journal of Bone and Mineral Research 24
12–21. (doi:10.1359/jbmr.080901)Received in final form 7 August 2013
Accepted 19 August 2013
Accepted Preprint published online 19 August 2013Published by Bioscientifica Ltd
Downloaded from Bioscientifica.com at 01/24/2020 02:11:45PM
via free access
